EFSp-GFP-YAP (5SA) Citations (2)

Originally described in: Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activity.
Pearson JD, Huang K, Pacal M, McCurdy SR, Lu S, Aubry A, Yu T, Wadosky KM, Zhang L, Wang T, Gregorieff A, Ahmad M, Dimaras H, Langille E, Cole SPC, Monnier PP, Lok BH, Tsao MS, Akeno N, Schramek D, Wikenheiser-Brokamp KA, Knudsen ES, Witkiewicz AK, Wrana JL, Goodrich DW, Bremner R Cancer Cell. 2021 Jul 13. pii: S1535-6108(21)00338-X. doi: 10.1016/j.ccell.2021.06.016. PubMed Journal

---

Articles Citing EFSp-GFP-YAP (5SA)

Articles
Netrin-1 and UNC5B Cooperate with Integrins to Mediate YAP-Driven Cytostasis. Pearson JD, Huang K, Dela Pena LG, Ducarouge B, Mehlen P, Bremner R. Cancer Res Commun. 2024 Sep 1;4(9):2374-2383. doi: 10.1158/2767-9764.CRC-24-0101. PubMed
MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines. Ryu HM, Kim D, Choi JY, Yoon S, Lee HS, Park JE, Lee E, Sung Y, Lee CH, Lee EY, Kim W, Seo S, Kim SW, Park KS, Lee DH. Cell Mol Life Sci. 2025 Aug 20;82(1):314. doi: 10.1007/s00018-025-05791-w. PubMed

If you have published an article using this material, please email us at to have your article added to this page.